Clinical Trial Update: A Study of BL-M08D1 in Patients With Relapsed or Refractory Lymphoid Malignancies [Phase 1]

View source ↗

Summary

This ClinicalTrials.gov listing describes a Phase 1 study of BL-M08D1 in patients with relapsed or refractory lymphoid malignancies, and the study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoid Malignancies

Drugs mentioned

• BL-M08D1

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Relapsed or Refractory Lymphoid Malignancies | Phase 1 | Status: RECRUITING